Baseline immunosuppression is associated with histological findings in early protocol biopsies

Transplantation

Volumn 78, Issue 7, 2004, Pages 1064-1068

  Moreso, Francesc ^a   Serón, Daniel ^a   Carrera, Marta ^a   Gil Vernet, Salvador ^a   Cruzado, Josep M ^a   Hueso, Miguel ^a   Fulladosa, Xavier ^a   Ramos, Rosa ^a   Ibernon, Meritxell ^a   Castelao, Alberto M ^a   Grinyó, Josep M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Renal transplantation; Subclinical rejection; Tacrolimus

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 6344247458     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000137268.85155.11     Document Type: Article

References (18)

1. Isoniemi HM, Krogerus L, von Willebrand E, et al. Histopathological findings in well functioning long term renal allografts. Kidney Int 1992; 41:155.
2. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 1995; 59: 511.
3. Serón D, Moreso F, Fulladosa X, et al. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 2002; 61: 727.
4. Nankivell BJ, Borrows RJ, Fung CLS, et al. The natural history of chronic allograft nephropathy. N Eng J Med 2003; 349: 2326.
5. Rush DN, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: a randomised study. J Am Soc Nephrol 1998; 9: 2129.
6. Nickerson P, Jeffery J, Gough J, et al. Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: a pilot study. J Am Soc Nephrol 1999; 10: 1801.
7. Johnson C, Ahsan N, Gonwa T, et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69: 834.
8. Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with Neoral and Tacrolimus: a paired kidney analysis. J Am Soc Nephrol 2003; 14: 2980.
9. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney trasnplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998; 66: 1736.
10. Gloor JM, Cohen AJ, Lager DJ, et al. Subclinical rejection in tacrolimus treated renal transplant recipients. Transplantation 2002; 73: 1965.
11. Serón D, Moreso F, Bover J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 311.
12. Serón D, Moreso F, Ramon JM, et al. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft rejection. Transplantation 2000; 69: 1849.
13. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification for renal allograft pathology. Kidney Int 1999; 55: 713.
14. Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: report of the CERTAP project. Kidney Int 2001; 60: 1198.
15. Furness PN, Taub N, Assmann KJ, et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805.
16. Zucker K, Rosen A, Tsaroucha A, et al. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patient receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol 1997; 5: 225.
17. Halloran P, Mathew S, Tomlanovich S, et al. Mycophenolate mofetil in renal allograft recipients. A pooled efficacy analysis of three randomised, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63: 39.
18. Regele H, Böhmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371.